| Trial ID: | L3841 |
| Source ID: | NCT00832481
|
| Associated Drug: |
Repaglinide
|
| Title: |
Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Repaglinide|DRUG: Metformin
|
| Outcome Measures: |
Primary: To investigate the effects of monotherapy of either repaglinide or metformin on glucose excursion after 3 months treatment in newly diagnosed type 2 diabetes patients in China, from Jan.01 2009 to Oct.30,2009 |
|
| Sponsor/Collaborators: |
Sponsor: Chinese PLA General Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
|
| Start Date: |
2009-01
|
| Completion Date: |
2009-12
|
| Results First Posted: |
|
| Last Update Posted: |
2009-08-25
|
| Locations: |
PLA General Hospital, Beijing, Beijing, 100000, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00832481
|
